Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

287 trials

NCT07155148
Recruiting
Argentine Registry of Crohn's Disease and Ulcerative Colitis
Not applicable · Argentina · 1 site
Registry update: 23 Sept 2025
NCT06756100
Recruiting
Early Inflammatory Bowel Disease Progression
Not applicable · Chile · 1 site
Registry update: 1 Jan 2025
NCT04806620
Recruiting
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Not applicable · United States · 1 site
Registry update: 22 Jan 2026
NCT05733845
Recruiting
Evaluation of Molecular Mechanisms of Non-response to Therapy in Patients With Inflammatory Bowel Disease
Not applicable · France · 1 site
Registry update: 6 May 2025
NCT05722236
Recruiting
IBD Strong Peer2Peer for Self-Management of Psychological Distress
Not applicable · Canada · 1 site
Registry update: 9 Sept 2026
NCT05442567
Recruiting
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Phase 3 · Australia, Belgium, Canada, China, Czechia, Spain, United Kingdom, Greece, Croatia, Hungary, Israel, Italy, Japan, South Korea, Lithuania, Poland, Slovakia, United States · 90 sites
Registry update: 7 May 2026
NCT05666960
Recruiting
R-3750 in Patients With Mild to Moderate Ulcerative Colitis
Phase 1 · United States · 5 sites
Registry update: 12 Jun 2026
NCT05739864
Recruiting
Superdonor FMT in Patients With Ulcerative Colitis
Phase 1/2 · Italy · 1 site
Registry update: 19 Mar 2026
NCT05574387
Recruiting
Metformin as Added on Therapy in Patients With Ulcerative Colitis
Phase 2 · Egypt · 1 site
Registry update: 4 Mar 2025
NCT07442045
Recruiting
Real-World Effectiveness and Safety of Upadacitinib Plus Vedolizumab vs Upadacitinib Monotherapy During Induction in Moderate-to-Severe Ulcerative Colitis
Not applicable · China · 6 sites
Registry update: 31 Jul 2026
NCT05610956
Recruiting
Evaluate the Possible Efficacy and Safety of Empagliflozin in Patient With Ulcerative Colitis
Early phase 1 · Egypt · 1 site
Registry update: 16 Jul 2025
NCT05287126
Recruiting
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
Phase 2 · Austria, Belgium, Spain, Japan, Poland, Slovakia, United States · 50 sites
Registry update: 27 Oct 2026
NCT06956703
Recruiting
NAZA - Nottingham/Astra ZenecA Prospective IBD Cohort Study
Not applicable · United Kingdom · 1 site
Registry update: 8 Jul 2026
NCT05679622
Recruiting
Fecal Microbiota Transplantation in Pediatric Ulcerative Colitis (UC)
Not applicable · China · 1 site
Registry update: 10 Jul 2026
NCT07132333
Recruiting
Molecular Inflammation Board at the Center for Personalized Medicine
Not applicable · Germany · 1 site
Registry update: 20 Aug 2025
NCT05230173
Recruiting
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Not applicable · United States · 24 sites
Registry update: 7 Aug 2026
NCT05294107
Recruiting
Intestinal Organoids
Not applicable · France · 1 site
Registry update: 17 Jun 2026
NCT05652621
Recruiting
Efficacy of Probiotics in Patients With IBD
Not applicable · China · 1 site
Registry update: 15 Dec 2022
NCT05456893
Recruiting
A Study to Evaluate Biomarkers in Moderate to Severe Ulcerative Colitis (UC) Patients Treated With Different Targeted Therapies
Not applicable · France · 1 site
Registry update: 6 May 2025
NCT04926103
Recruiting
Screening Donors, Fecal Microbiota Transplant Program in Ulcerative Colitis
Not applicable · Canada · 1 site
Registry update: 1 Oct 2024

Ordered by registry start date. Freshness and sponsorship never change the order.